Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum]

Kameoka Y, Kishi F, Koura M, et al. Drug Des Devel Ther. 2019;13:555–568.  The authors have advised that there was an error in the text.  Page 561, beginning at the left-hand bottom of the page, “The number of peripheral blood lymphocytes and g...

Full description

Bibliographic Details
Main Authors: Kameoka Y, Kishi F, Koura M, Yamakawa Y, Nagasawa R, Ito F, Matsuda J, Suzuki O, Nakayama T, Suzuki K
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Drug Design, Development and Therapy
Online Access:https://www.dovepress.com/corrigendum-efficacy-of-a-recombinant-single-chain-fragment-varia-peer-reviewed-article-DDDT